Joshua T. Brumm, CEO & President at Dyne Therapeutics, Inc. (DYN), sold 18,172 shares at $25.85 ($470K) on 2024-03-07, disclosed to the SEC on 2024-03-11.
Scheduled sale ($470k) by CEO & President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.85 | 9,086 | $235K | 50.0% |
| 2 | $25.85 | 9,086 | $235K | 50.0% |
| Total | $25.85 avg | 18,172 | $470K | 100% |
| Filing → |
| DYN | SELL | 2024-03-12 | $22.2M | — | Filing → |
| DYN | SELL | 2024-03-01 | $5.1M | — | Filing → |
| DYN | SELL | 2024-01-04 | $9.7M | — | Filing → |